Estrogen as Treatment for Anorexia Nervosa
About this study
Starts
1 April 2024
Ends
1 April 2026
Participants
Females aged 16 and over living with anorexia nervosa (including in partial remission and atypical anorexia nervosa)
What is Involved
5 Visits to our research site in Melbourne over a 3 month duration + 1 additional visit 3 months after end of treatment.
Location
607 St Kilda Road, Melbourne
Funding Source
Philanthropy
Ethics Approval Number
HREC/100958/Alfred-2023
Author Information
Research Team
Professor Jayashri Kulkarni, Dr Eva Gregertsen, Dr Romi Goldschlager, Dr Eveline Mu
Institution
Monash University
Contact Information
More Info Website
THRED@monash.edu
The Li-Transformative Hub for Research into Eating Disorders (Li-THRED) at Monash University is conducting a double-blinded randomised controlled trial exploring the effectiveness of estrogen to treat eating disorder symptoms in women with anorexia nervosa. It is hypothesised that estrogen will improve eating disorder symptoms as compared to placebo.
« Back to Participate in a Study